These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 204881)

  • 1. Thyrotropin-releasing hormone does not alter the release of melanocyte-stimulating hormone or adrenocorticotropic hormone from the rat pars intermedia.
    Kraicer J
    Neuroendocrinology; 1977; 24(3-4):226-31. PubMed ID: 204881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alpha-melanocyte stimulating hormone release in response to thyrotropin releasing hormone in healthy horses, horses with pituitary pars intermedia dysfunction and equine pars intermedia explants.
    McFarlane D; Beech J; Cribb A
    Domest Anim Endocrinol; 2006 May; 30(4):276-88. PubMed ID: 16115743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concomitant secretion of adrenocorticotropin, beta-endorphin, and gamma-melanotropin from perfused pituitary tumor cells of Cushing's disease: effects of lysine vasopressin, rat median eminence extracts, thyrotropin-releasing hormone, and luteinizing hormone-releasing hormone.
    Oki S; Nakao K; Tanaka I; Horii K; Nakai Y; Shimbo S; Watanabe M; Nakane T; Kuwayama A; Kageyama N; Imura H
    J Clin Endocrinol Metab; 1981 Jan; 52(1):42-9. PubMed ID: 6256404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Release of pro-opiomelanocortin-derived peptides from the pars intermedia and pars distalis of the rat pituitary: effect of corticotrophin-releasing factor and somatostatin.
    Kraicer J; Gajewski TC; Moor BC
    Neuroendocrinology; 1985 Nov; 41(5):363-73. PubMed ID: 2865690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma prolactin, thyroid-stimulating hormone, melanocyte-stimulating hormone, and adrenocorticotropin responses to thyrotropin-releasing hormone in mares treated with detomidine and butorphanol.
    Oberhaus EL; Thompson DL; Kerrigan LE; Chapman AM
    Domest Anim Endocrinol; 2021 Jan; 74():106536. PubMed ID: 32871339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. α-Melanocyte--stimulating hormone and adrenocorticotropin concentrations in response to thyrotropin-releasing hormone and comparison with adrenocorticotropin concentration after domperidone administration in healthy horses and horses with pituitary pars intermedia dysfunction.
    Beech J; McFarlane D; Lindborg S; Sojka JE; Boston RC
    J Am Vet Med Assoc; 2011 May; 238(10):1305-15. PubMed ID: 21568777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal changes in plasma adrenocorticotropic hormone and α-melanocyte-stimulating hormone in response to thyrotropin-releasing hormone in normal, aged horses.
    Funk RA; Stewart AJ; Wooldridge AA; Kwessi E; Kemppainen RJ; Behrend EN; Zhong Q; Johnson AK
    J Vet Intern Med; 2011; 25(3):579-85. PubMed ID: 21457320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pars intermedia ACTH and MSH content: effect of adrenalectomy, gonadectomy and a neurotropic (noise) stress.
    Kraicer J; Beraud G; Lywood DW
    Neuroendocrinology; 1977; 23(6):352-67. PubMed ID: 201881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pituitary proopiomelanocortin-derived peptides and hypothalamus-pituitary-interrenal axis activity in gilthead sea bream (Sparus aurata) during prolonged crowding stress: differential regulation of adrenocorticotropin hormone and alpha-melanocyte-stimulating hormone release by corticotropin-releasing hormone and thyrotropin-releasing hormone.
    Rotllant J; Balm PH; Ruane NM; Pérez-Sánchez J; Wendelaar-Bonga SE; Tort L
    Gen Comp Endocrinol; 2000 Aug; 119(2):152-63. PubMed ID: 10936035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Secretion of pro-opiocortin peptides from isolated perfused rat pars intermedia cells.
    Jackson S; Lowry PJ
    Neuroendocrinology; 1983 Oct; 37(4):248-57. PubMed ID: 6138722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between the release of corticotrophin and melanocyte-stimulating hormone from the pars intermedia of the rat pituitary gland [proceedings].
    Tilders FJ
    J Endocrinol; 1979 Feb; 80(2):8P. PubMed ID: 220371
    [No Abstract]   [Full Text] [Related]  

  • 12. Preprothyrotropin-releasing hormone-(178-199) does not inhibit corticotropin release.
    Nicholson WE; Orth DN
    Endocrinology; 1996 May; 137(5):2171-4. PubMed ID: 8612564
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of in vivo and in vitro corticotropin-releasing hormone-stimulated release of proopiomelanocortin-derived peptides in cats.
    Willemse T; Mol JA
    Am J Vet Res; 1994 Dec; 55(12):1677-81. PubMed ID: 7887510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropeptide Y inhibits thyrotropin-releasing hormone-induced stimulation of melanotropin release from the intermediate lobe of the frog pituitary.
    Danger JM; Lamacz M; Mauviard F; Saint-Pierre S; Jenks BG; Tonon MC; Vaudry H
    Gen Comp Endocrinol; 1990 Jan; 77(1):143-9. PubMed ID: 2104815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in plasma melanocyte-stimulating hormone, ACTH, prolactin, GH, LH, FSH, and thyroid-stimulating hormone in response to injection of sulpiride, thyrotropin-releasing hormone, or vehicle in insulin-sensitive and -insensitive mares.
    Valencia NA; Thompson DL; Mitcham PB
    Domest Anim Endocrinol; 2013 May; 44(4):204-12. PubMed ID: 23571008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual effects of thyrotrophin-releasing hormone (TRH) on K+ conductance in frog pituitary melanotrophs. TRH-induced alpha-melanocyte-stimulating hormone release is not mediated through voltage-sensitive K+ channels.
    Louiset E; Cazin L; Lamacz M; Tonon MC; Vaudry H
    J Mol Endocrinol; 1989 Nov; 3(3):207-18. PubMed ID: 2511851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic mediation of the effect of elevated potassium on the release of pro-opiomelanocortin-derived peptides from the pars intermedia of the rat pituitary.
    Randle JC; Moor BC; Kraicer J
    Neuroendocrinology; 1983 Aug; 37(2):141-9. PubMed ID: 6193453
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro release of ACTH from dispersed rat pars intermedia cells. II. Effect of neurotransmitter substances.
    Kraicer J; Morris AR
    Neuroendocrinology; 1976; 21(2):175-92. PubMed ID: 13323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innervation of the pars intermedia and control of alpha-melanotropin secretion in the newt.
    Danger JM; Perroteau I; Franzoni MF; Saint-Pierre S; Fasolo A; Vaudry H
    Neuroendocrinology; 1989 Nov; 50(5):543-9. PubMed ID: 2514395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation and secretion of proopiomelanocortin peptides from isolated perifused dog pituitary pars intermedia cells.
    Kemppainen RJ; Zerbe CA; Sartin JL
    Endocrinology; 1989 May; 124(5):2208-17. PubMed ID: 2539971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.